Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,232,000 | 6,166,000 | 4,458,000 | 4,817,000 | 5,762,000 |
| Marketable Securities | 230,000 | 77,000 | 440,000 | 70,000 | 61,000 |
| Inventories | 4,967,000 | 4,699,000 | 5,078,000 | 6,220,000 | 7,624,000 |
| Other current assets | 10,837,000 | 10,322,000 | 10,248,000 | 9,810,000 | 9,200,000 |
| TOTAL | $22,266,000 | $22,593,000 | $20,224,000 | $20,917,000 | $22,647,000 |
| Non-Current Assets | |||||
| PPE Net | 9,599,000 | 9,449,000 | 9,227,000 | 9,627,000 | 10,015,000 |
| Intangibles | 59,292,000 | 59,127,000 | 59,292,000 | 59,721,000 | 61,228,000 |
| Other Non-Current Assets | 5,530,000 | 5,314,000 | 5,442,000 | 6,314,000 | 6,383,000 |
| TOTAL | $74,421,000 | $73,890,000 | $73,961,000 | $75,662,000 | $77,626,000 |
| Total Assets | $96,687,000 | $96,483,000 | $94,185,000 | $96,579,000 | $100,273,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,625,000 | 5,314,000 | 5,408,000 | 2,162,000 | 2,069,000 |
| Accounts payable and accrued liabilities | 19,210,000 | 2,550,000 | 17,694,000 | 17,821,000 | 17,864,000 |
| TOTAL | $24,860,000 | $26,293,000 | $24,850,000 | $21,815,000 | $22,740,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 26,916,000 | 22,965,000 | 23,013,000 | 26,461,000 | 28,081,000 |
| Other Non-Current Liabilities | 5,553,000 | 6,463,000 | 7,001,000 | 6,373,000 | 6,724,000 |
| TOTAL | $36,016,000 | $33,132,000 | $34,181,000 | $38,813,000 | $41,174,000 |
| Total Liabilities | $60,876,000 | $59,425,000 | $59,031,000 | $60,628,000 | $63,914,000 |
| Shareholders' Equity | |||||
| Common Shares | 387,000 | 387,000 | 387,000 | 387,000 | 387,000 |
| Retained earnings | -1,825,000 | -574,000 | -2,471,000 | -1,657,000 | -1,228,000 |
| Other shareholders' equity | 2,068,000 | 1,916,000 | 2,081,000 | 2,068,000 | 2,050,000 |
| TOTAL | $35,789,000 | $37,037,000 | $35,134,000 | $35,932,000 | $36,340,000 |
| Total Liabilities And Equity | $96,665,000 | $96,462,000 | $94,165,000 | $96,560,000 | $100,254,000 |